This rapid market expansion presents significant opportunities for pharmaceutical companies who are able to develop new therapies to address the unmet clinical needs in type 2 diabetes. In contrast, Datamonitor expects opportunities in
Learn more about it
Related posts:
- The Diabetes Market Outlook To 2014 Market Dynamics Competitive Landscape Emerging Therapies DUBLIN—-Research and Markets has announced the addition of the “The...
- 2 Triad Biotech Companies To Market Diabetes Blood Test Two biotechnology companies with operations in Piedmont Triad Research Park...
- Diabetes Diagnosis Treatment And Drug Delivery Market Will Almost Triple In Value By 2016 Says IData Research Continuous Glucose Monitoring Systems Market to Grow 48% in 2009...
- Type 2 Diabetes Drug Pipeline Analysis And Market Forecasts To The type-2 Diabetes Market is forecast to Grow at a...
- Exenatide Clinical Data Analysis Shows No Increased Risk Of Since 1923, Lilly has been the industry leader in pioneering...
